CDNA
CareDx IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$858.41M
P/E Ratio
—
EPS
$-0.40
Beta
2.54
52W High
$21.48
52W Low
$10.96
50-Day MA
$18.68
200-Day MA
$16.73
Dividend Yield
—
Profit Margin
-5.62%
Forward P/E
74.07
PEG Ratio
-0.12
About CareDx Inc
CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $379.81M |
| Gross Profit (TTM) | $256.57M |
| EBITDA | $-7.79M |
| Operating Margin | -3.49% |
| Return on Equity | -6.27% |
| Return on Assets | -3.15% |
| Revenue/Share (TTM) | $7.13 |
| Book Value | $5.95 |
| Price-to-Book | 3.09 |
| Price-to-Sales (TTM) | 2.26 |
| EV/Revenue | 2.071 |
| EV/EBITDA | 65.47 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 25.20% |
| Shares Outstanding | $51.22M |
| Float | $49.68M |
| % Insiders | 4.46% |
| % Institutions | 101.72% |
Historical Volatility
HV 10-Day
49.89%
HV 20-Day
43.15%
HV 30-Day
42.53%
HV 60-Day
58.53%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($24.80 target)
3
Buy5
HoldData last updated: 4/10/2026